Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Fish and Richardson
Cantor Fitzgerald
Deloitte
Citi

Generated: March 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Molidustat

« Back to Dashboard

US Patents for Molidustat

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molidustat ➤ Sign Up Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH (Monheim, DE) ➤ Sign Up
Molidustat ➤ Sign Up Substituted sodium 1H-pyrazol-5-olate Bayer Intellectual Property GmbH (Monheim, DE) ➤ Sign Up
Molidustat ➤ Sign Up Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH (Monheim, DE) ➤ Sign Up
Molidustat ➤ Sign Up Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH (Monheim, DE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Molidustat

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Molidustat Argentina 063392 2026-10-26 ➤ Sign Up
Molidustat Australia 2007328052 2026-10-26 ➤ Sign Up
Molidustat Brazil PI0717367 2026-10-26 ➤ Sign Up
Molidustat Canada 2667382 2026-10-26 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Farmers Insurance
Colorcon
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: